gip/glp-1 The activity of GLP-1 and GIP for Type 2 Diabetes and Obesity Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)

Glucagon-like peptide-1 receptor (GLP-1) agonists are an effective treatment for controlling blood glucose levels in people with type 2 diabetes, particularly those who do not respond, or stop responding to, first-line treatments, such as metformin

Patients 13 and older diagnosed with severe obesity should be evaluated for bariatric surgery, the authors wrote

Given the differences in the MedDRAs categorization rules, some potential PTs that were not included may exist, e.g., depression suicidal (belonging to HLGT level, depressed mood disorders and disturbances) and intentional overdose (belonging to HLGT level, overdoses, and underdoses NEC)

PlexusDx emphasizes that symptom reportingincluding any chest sensationshelps providers adjust your dose or timing to maximize tolerability

For tablets like Rybelsus, food reduces absorption by more than 50%, essentially wasting the dose

Central sensitization is more complex and more concerning